Genovate Biotechnology Co., Ltd. (TPEX:4130)
Taiwan
· Delayed Price · Currency is TWD 32.50
-2.10 (-6.07%)
Mar 9, 2026, 1:30 PM CST
Genovate Biotechnology Market Cap
Genovate Biotechnology has a market cap or net worth of 3.70 billion as of March 9, 2026. Its market cap has increased by 39.29% in one year.
Market Cap
3.70B
Enterprise Value
3.22B
Revenue
492.41M
Ranking
n/a
PE Ratio
316.46
Stock Price
32.50
Market Cap Chart
Since November 3, 2008, Genovate Biotechnology's market cap has increased from 664.80M to 3.70B, an increase of 456.09%. That is a compound annual growth rate of 10.40%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 4.08B |
| ACRO Biomedical | 3.75B |
| Energenesis Biomedical CO.,LTD. | 4.18B |
| Medigen Biotechnology | 4.20B |
| Sagittarius Life Science | 3.51B |
| BRIM Biotechnology | 3.44B |
| Shine-On BioMedical | 3.43B |
| BioGend Therapeutics | 4.53B |